Novacyt S.A Investor Presentation 2016

Novacyt S.A presented its investor strategy in May 2016, outlining its ambition to become a leader in cytology and molecular diagnostics for oncology and infectious disease. The presentation outlines the company's proposed strategy, plans and objectives in the diagnostic testing sector.